ESSA Pharma Inc (EPIX)
6.25
+0.05
(+0.81%)
USD |
NASDAQ |
May 16, 16:00
6.24
-0.01
(-0.16%)
Pre-Market: 20:00
ESSA Pharma Enterprise Value: 141.38M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 141.38M |
| May 15, 2024 | 139.16M |
| May 14, 2024 | 130.29M |
| May 13, 2024 | 127.18M |
| May 10, 2024 | 140.94M |
| May 09, 2024 | 141.38M |
| May 08, 2024 | 163.12M |
| May 07, 2024 | 166.67M |
| May 06, 2024 | 173.77M |
| May 03, 2024 | 169.33M |
| May 02, 2024 | 172.43M |
| May 01, 2024 | 157.79M |
| April 30, 2024 | 149.37M |
| April 29, 2024 | 136.50M |
| April 26, 2024 | 133.84M |
| April 25, 2024 | 135.61M |
| April 24, 2024 | 141.38M |
| April 23, 2024 | 148.03M |
| April 22, 2024 | 148.03M |
| April 19, 2024 | 144.49M |
| April 18, 2024 | 162.23M |
| April 17, 2024 | 177.76M |
| April 16, 2024 | 193.73M |
| April 15, 2024 | 187.96M |
| April 12, 2024 | 208.37M |
| Date | Value |
|---|---|
| April 11, 2024 | 230.11M |
| April 10, 2024 | 211.92M |
| April 09, 2024 | 207.04M |
| April 08, 2024 | 233.66M |
| April 05, 2024 | 235.87M |
| April 04, 2024 | 226.11M |
| April 03, 2024 | 219.02M |
| April 02, 2024 | 227.89M |
| April 01, 2024 | 237.65M |
| March 28, 2024 | 233.46M |
| March 27, 2024 | 236.56M |
| March 26, 2024 | 249.39M |
| March 25, 2024 | 257.79M |
| March 22, 2024 | 257.35M |
| March 21, 2024 | 264.43M |
| March 20, 2024 | 264.87M |
| March 19, 2024 | 269.29M |
| March 18, 2024 | 260.45M |
| March 15, 2024 | 256.02M |
| March 14, 2024 | 251.60M |
| March 13, 2024 | 257.79M |
| March 12, 2024 | 252.93M |
| March 11, 2024 | 256.47M |
| March 08, 2024 | 265.31M |
| March 07, 2024 | 243.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-101.13M
Minimum
Oct 11 2022
1.187B
Maximum
Mar 12 2021
174.28M
Average
71.17M
Median
Dec 16 2019
Enterprise Value Benchmarks
| Acasti Pharma Inc | 0.8274M |
| Aurinia Pharmaceuticals Inc | 474.73M |
| Edesa Biotech Inc | 11.74M |
| Lexaria Bioscience Corp | 35.30M |
| Xenon Pharmaceuticals Inc | 2.345B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.990M |
| Total Expenses (Quarterly) | 10.49M |
| EPS Diluted (Quarterly) | -0.20 |
| Earnings Yield | -10.08% |